logo

For the Inventor, By the Inventor

Munich, Germany

Klinge Pharma Gmbh


USPTO Granted Patents = 23

% Expired Patents = 4.3


Trademarks = 4

Forward Citations = 459

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Friedemann Reiter (10 out of 14 patents)

silverMedal Klaus Seibel (9 out of 13 patents)

bronzeMedal Benno Rattel (5 out of 15 patents)

4.  Elfi Biedermann (5 out of 9 patents)

5.  Max Hasmann (5 out of 9 patents)

6.  Barbara Schein (5 out of 9 patents)

7.  Klaus Vogt (5 out of 9 patents)

8.  Helmut Grill (5 out of 10 patents)

9.  Roland Löser (4 out of 4 patents)

10.  Fritz Stanislaus (4 out of 5 patents)

11.  Roland Loser (4 out of 8 patents)

12.  Michael Schliack (4 out of 6 patents)

13.  Katja Wosikowski (3 out of 6 patents)

14.  Isabel Schemainda (3 out of 5 patents)

15.  Gerhard Schneider (3 out of 3 patents)


23 patents:

1. 6903118 - Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides (2005-06-07),
2. 6593344 - Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides (2003-07-15),
3. 6506572 - Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy (2003-01-14),
4. 6451816 - Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression (2002-09-17),
5. 6444823 - Pyridyl alkane acid amides as cytostatics and immunosuppressives (2002-09-03),
6. 6419959 - Galenic composition containing opioid antagonists (2002-07-16),
7. 6077534 - Production of pharmaceutical formulations for treatment of edema and (2000-06-20),
8. 5693863 - Method for the production of E-1-�4'- (2- Dimethylaminoethoxy) - (1997-12-02),
9. 5493051 - Lifibrol and its use (1996-02-20),
10. 5391375 - Transdermal therapeutical system with physostigmine as active component (1995-02-21),
11. 5266721 - Process for preparing the pure enantiomers of lifibrol and its alkyl (1993-11-30),
12. 5254594 - Remedies for bone diseases (1993-10-19),
13. 5153353 - p-Oxybenzoic acid derivatives, process for the preparation thereof and (1992-10-06),
14. 5149865 - New p-oxibenzoic acid derivatives, process for their preparation and (1992-09-22),
15. 5089267 - Transdermal therapeutical system comprising physostigmine as active (1992-02-18),
Company Overview
Klinge Pharma GmbH is a pharmaceutical company based in Munich, Germany, specializing in the development and manufacturing of high-quality generic and specialty pharmaceuticals. The company focuses on various therapeutic areas, including oncology, cardiology, and infectious diseases, leveraging advanced research and technology to enhance patient care. Klinge Pharma is committed to innovation and quality, ensuring that its products meet rigorous standards for safety and efficacy in the global market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#118 in W-8000 Munich

#1,984 in Germany

#27,685 in the World

Munich, DE
Munich, Germany

Klinge Pharma Gmbh

Forward Citations = 459

50 inventors:

goldMedal Friedemann Reiter (10 out of 14 patents)

silverMedal Klaus Seibel (9 out of 13 patents)

bronzeMedal Benno Rattel (5 out of 15 patents)

4.  Elfi Biedermann (5 out of 9 patents)

5.  Max Hasmann (5 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Klinge Pharma Gmbh. Retrieved from https://idiyas.com/company/klinge-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…